Johnson & Johnson - About the company
Johnson & Johnson is a public company based in New Brunswick (United States), founded in 1886 by Edward Mead Johnson and Tyler Rochwerg. It operates as a Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products. Johnson & Johnson has raised an undisclosed amount in funding. The company has 1278 active competitors, including 69 funded and 163 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.
Company Details
Manufacturer, developer, and supplier of beauty care products, medical devices, and pharmaceutical products. The company working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. It also pride on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability with an extended supply base comprising about 50,000 suppliers across our three business segments. In 2022, the company recorded annual revenues of $96.31B and a net profit of $12.72B.
- Website
- www.jnj.com/
- Registered Address
- Higi House, L.B.S. Marg, Mulund West, Mumbai, Mumbai, Mumbai, Maharashtra, India, 400080
Key Metrics
Founded Year
1886
Location
New Brunswick, United States
Stage
Public
Latest Funding Round
Investors
Ranked
5th among 1278 active competitors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
127,502 as on May 31, 2026
Exit Details
Public
Legal entities associated with Johnson & Johnson
Johnson & Johnson is associated with 12 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
JOHNSON & JOHNSON PRIVATE LIMITED CIN: U33110MH1957PTC010928 , India, Active | Sep 05, 1957 | ₹1,000+ Cr (As on Mar 31, 2025) | 1837 (As on Feb 01, 2026) | |
J&J XXX LTD CIN: 13342325 , United Kingdom, Active | Apr 18, 2021 | £0 - £1M (As on Apr 30, 2023) | - | |
JOHNSON & JOHNSON CIN: 200406 , United States, Active | $1B+ (As on Dec 31, 2025) | 131900 (As on Dec 31, 2023) | - | |
H+A+D Marketing Corporation s. r. o. CIN: 08217602 , Czech Republic, Active | May 30, 2019 | - | - | |
J&J marketing business s.r.o. CIN: 29450969 , Czech Republic, Active | Sep 05, 2012 | - | - | |
JOHNSON & JOHNSON SURGICAL VISION INDIA PRIVATE LIMITED CIN: U24231KA2004PTC034235 , India, Active | Jun 29, 2004 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | 214 (As on Oct 31, 2024) | |
JJ SUPPORT s.r.o. CIN: 06711570 , Czech Republic, Active | Dec 22, 2017 | - | - | |
Pharma Vision Technology s.r.o. CIN: 29396638 , Czech Republic, Active | Feb 09, 2012 | - | - | |
Health 4 Beauty s.r.o. CIN: 17126215 , Czech Republic, Active | May 10, 2022 | - | - | |
JOHNSON & JOHNSON SERVICES, INC. CIN: 3591138 , United States, Active | Nov 13, 2002 | $1B+ (As on Dec 31, 2023) | - | - |
J&J Provider s.r.o. CIN: 17721296 , Czech Republic, Active | Nov 09, 2022 | - | - | |
W & J Partner s. r. o. CIN: 47666455 , Czech Republic, Active | Dec 17, 1992 | - | - |
Johnson & Johnson's IPO details
Johnson & Johnson got listed on Jan 06, 1978.
Click here to take a look at Johnson & Johnson's IPO in detail
Sign up to download Johnson & Johnson's company profile
Johnson & Johnson's funding and investors
Johnson & Johnson has raised funding over 3 rounds. Its first funding round was on Nov 05, 2018. Johnson & Johnson has 18 institutional investors.
Here is the list of recent funding rounds of Johnson & Johnson:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 20, 2025 | 1923214 | Conventional Debt | 6238012 | 8870748 | 6962486 | 4328357 |
May 01, 2023 | 6320628 | Grant (prize money) | 6183633 | 4602028 | 1022426 | |
Nov 05, 2018 | 7920045 | Post IPO | 8764531 | 3398168 | 4649256 |
View details of Johnson & Johnson's funding rounds and investors
Johnson & Johnson's founders and board of directors
Founder? Claim ProfileThe founders of Johnson & Johnson are Edward Mead Johnson and Tyler Rochwerg. Joaquin Duato is the CEO of Johnson & Johnson.
Here are the details of Johnson & Johnson's key team members:
- Edward Mead Johnson: Former Co-Founder of Johnson & Johnson and founder of 1 other company. Contact Info: 1 email address
- Tyler Rochwerg: Former Co-Founder of Johnson & Johnson.
- Joaquin Duato: CEO of Johnson & Johnson. Contact Info: 3 email addresses
View details of Johnson & Johnson's Founder profiles and Board Members
Johnson & Johnson's employee count trend
Johnson & Johnson has 127,502 employees as of May 26. Here is Johnson & Johnson's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Johnson & Johnson's Competitors and alternates
Top competitors of Johnson & Johnson include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Johnson & Johnson, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 79/100 | |
5th | Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 76/100 | |
6th | AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 73/100 | |
7th | Pfizer 1849, New York City (United States), Public | Provider of pharmaceutical products for multiple disease treatments | - | 72/100 | |
8th | Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 72/100 | |
9th | ![]() Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public | Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others | - | 71/100 | |
10th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 70/100 |
Looking for more details on Johnson & Johnson's competitors? Click here to see the top ones
Johnson & Johnson's Investments and acquisitions
Johnson & Johnson has made 37 investments in companies including SonoThera and Mestag Therapeutics. Johnson & Johnson has also acquired 59 companies including Firefly Bio and Atraverse Medical.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 10, 2026 | Investments | 2022 | San Francisco (United States) | |
Jun 08, 2026 | Acquisition | 2022 | San Francisco (United States) | |
Apr 24, 2026 | Acquisition | 2022 | Chicago (United States) |
See all investments and acquisitions by Johnson & Johnson
Reports related to Johnson & Johnson
Here is the latest report on Johnson & Johnson's geography:
News related to Johnson & Johnson
Media has covered Johnson & Johnson for a total of 512 events in the last 1 year, 333 of them have been about company updates and 13 about people movement.
•
J&J Reports Positive Phase II/III ENERGY Trial Data for Nipocalimab in Warm Autoimmune Hemolytic Anemiaclinicaltrialsarena.com•Jun 12, 2026•Johnson & Johnson
•
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL for Cataract SurgeonsBusiness Wire•Jun 11, 2026•Johnson & Johnson
•
Johnson & Johnson Wins Ovarian Cancer Talc Lawsuit in CaliforniaGlobal CosmeticNews•Jun 09, 2026•Johnson & Johnson
•
Johnson & Johnson to Acquire Firefly Bio for $1 BillionGrupoglobo•Jun 08, 2026•Firefly Bio, Johnson & Johnson, Firefly BioWorks, Easterly
•
•
•
Johnson & Johnson's VARIPULSE™ Platform Receives First Approval in India for Atrial Fibrillation TreatmentBusiness Wire India•Jun 04, 2026•Johnson & Johnson
•
J&J's nipocalimab shows efficacy in Phase II JASMINE study for lupus treatmentHospital Management•Jun 04, 2026•Johnson & Johnson
•
•
Are you a Founder ?
FAQs about Johnson & Johnson
Explore our recently published companies
- Kela - 2024 founded, Funding Raised company
- BHI - New York City based, 2026 founded, Unfunded company
- Sherwood Crown Investment - Nottingham based, 2024 founded, Unfunded company
- Roman Tiles - London based, 2019 founded, Unfunded company
- Fox59 - 1996 founded, Unfunded company
- Kfor - 1995 founded, Unfunded company

